New Gene Therapy for Sickle Cell Disease Shows Promise in Trials
University of Chicago Medical Center
Trial findings add to growing body of evidence supporting CRISPR-Cas9-led gene therapies for genetic diseases
Genetic testing is currently limited to patients with a high-risk family history